PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
PetVivo Holdings, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.75+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $27.79M
- P/E (TTM)
- –
- Dividend yield
- –
PetVivo Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Sales to Vedco [Member] | $809.16K | $288.93K | $0 | – | 70.9% | +180.1% |
| Sales To Clipper [Member] | $40.52K | $194.50K | $0 | – | 3.5% | -79.2% |
| Product [Member] | $0 | $430.82K | $626.18K | $636.35K | 0.0% | -100.0% |
| Sales to Convetrus [Member] | $0 | $44.02K | $105.64K | – | 0.0% | -100.0% |
By region
From the segment and revenue-disaggregation notes of PetVivo's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.